![Han Jung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Han Jung
Corporate Officer/Principal bei Korean Institute of Certified Public Accountants
Aktive Positionen von Han Jung
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Korean Institute of Certified Public Accountants | Corporate Officer/Principal | - | - |
Karriereverlauf von Han Jung
Ehemalige bekannte Positionen von Han Jung
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Glycostem Therapeutics BV
![]() Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Niederlande | 2 |
Südkorea | 2 |
Operativ
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Glycostem Therapeutics BV
![]() Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands. | Health Technology |
Korean Institute of Certified Public Accountants |